The study led by the University of Cambridge was presented at the European Association of Urology 2019 congress last weekend.

Real-life data show a higher risk for thrombocytopenia and spinal cord compression than was found in the ALSYMPCA trial.

The finding may call into question the general applicability of Nobel Prize winning hormonal prostate treatment.

NNS of 579 and NND of 18 to prevent 1 death.

Project links 11 organisations across the South East of England, France, Belgium and the Netherlands.

Providers should “strongly recommend” drug to increase treatment efficacy.

In nonrandomized study, testosterone completely prevented progression.

Healthful eating may boost reproductive health.

Findings may motivate men to adhere to hypertension treatments.

A possible explanation for increased CV risk in patients with hypogonadism.

The findings suggest older adults with urinary tract infection should immediately be initiated on antibiotics.

Results from the EPIC study.

Patients had received a median 14 years of ART.

Antibiotics are being prescribed for longer than recommended in a significant proportion of patients.